Pharmacotherapeutic group: throat preparations, antiseptics, other throat antiseptics. ATC code: R02AA20.
Through its combination of active substances, Aspegola exerts local antiseptic, bactericidal, fungicidal, and analgesic effects.
This medicinal product contains:
2,4-dichlorobenzyl alcohol and amylmetacresol, two antiseptics with antibacterial, antiviral, and antifungal activity against pathogenic bacterial flora of the oral cavity. These two active substances belong to the chemical classes of alcohols and phenols, respectively.
Lidocaine, an amide-type local anaesthetic that provides rapid, intense, and sustained pain relief.
Lozenges containing the combination of amylmetacresol and 2,4-dichlorobenzyl alcohol have been investigated in several clinical trials in adult patients. The results demonstrated significant analgesic, functional, sensory, and psychological effects, with onset within 1–5 minutes and a duration of up to 2 hours following administration as lozenges.
Warnings
If symptoms persist or worsen after 3 to 4 days, or if additional symptoms such as high fever, headache, nausea, or vomiting develop, a doctor should be consulted.
Excessive dosing, overly short dosing intervals, or use of the product on damaged mucosa may lead to increased plasma concentrations and serious adverse reactions (see section 4.9). The product should not be applied to the oral cavity or throat in the presence of larger acute wounds.
The product should be administered with caution in acutely unwell or frail elderly patients, who are more susceptible to the adverse effects of this medicinal product.
Aspegola may cause numbness of the tongue and may increase the risk of bite injury. The throat anaesthesia induced by this medicinal product may lead to pulmonary aspiration (coughing while eating that gives the impression of choking). Patients should be aware that the induction of topical anaesthesia may impair swallowing and thereby increase the risk of aspiration. It is therefore essential that this product is not used before eating or drinking.
This medicinal product contains isomalt and maltitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.
This medicinal product contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially "sodium-free".
The colouring agent sunset yellow FCF (E110) may cause allergic reactions.
